In this study, we are interested in understanding the potential prognostic value and the regulatory mechanism of WDR5 expression for breast cancer survival, particularly for patients receiving the anthracycline regimen (a chemotherapy commonly used in breast cancer). Here, WDR5 is linked to breast carcinoma.